Ligand validation:1OJ4

CDM: 4-DIPHOSPHOCYTIDYL-2-C-METHYL-D-ERYTHRITOL

CDM is a Ligand Of Interest in 1OJ4 designated by the RCSB

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
1OJ4_CDM_A_1284	67%	18%	0.109	0.918	2.41	1.13	7	2	0	0	100%	1
1OJ4_CDM_B_1284	38%	15%	0.149	0.852	2.61	1.22	7	5	2	0	100%	1
8QC7_CDM_A_301	78%	10%	0.09	0.932	3.52	0.94	14	2	0	0	100%	1
2V2Z_CDM_A_1269	90%	59%	0.09	0.972	0.73	0.84	1	1	0	0	100%	1
3Q80_CDM_B_501	90%	9%	0.097	0.979	2.99	1.5	8	6	0	0	100%	1
1INI_CDM_A_1001	85%	18%	0.096	0.962	2.1	1.47	9	6	0	0	100%	1
1U40_CDM_A_669	56%	41%	0.177	0.949	1.27	1.04	5	2	1	0	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.